INS and type 2 diabetes mellitus: Liver glycogen content is normalized, or even elevated, with exogenous insulin treatment in T1D (Chatila and West, 1996; Tsujimoto et al., 2006; Julián et al., 2015) and this phenomenon appears to be reflected in our model of T2D when compared to HFF controls (Figure 4E).